Tamsin K Phillips1,2, Pheposadi Mogoba1,2, Kirsty Brittain1,2, Yolanda Gomba1,2, Allison Zerbe3, Landon Myer1,2, Elaine J Abrams3,4. 1. Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa. 2. Centre for Infectious Diseases Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. 3. ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY; and. 4. Vagelos College of Physicians & Surgeons, Columbia University, New York, NY.
Abstract
BACKGROUND: Integrated maternal and child health (MCH) services improve women's postpartum antiretroviral therapy (ART) outcomes during breastfeeding; however, long-term outcomes after transfer to general ART services remain unknown. METHODS: The MCH-ART trial demonstrated that maternal retention and viral suppression at 12-months postpartum were improved significantly among women randomized to integrated MCH services continued in the antenatal clinic through cessation of breastfeeding (MCH-ART arm) compared with immediate transfer to general ART services postpartum (standard of care). We reviewed electronic health records for all women who participated in the MCH-ART trial to ascertain retention and gaps in care and invited all women for a study visit 36- to 60-months postpartum including viral load testing. RESULTS: Of 471 women in MCH-ART, 450 (96%) contributed electronic health record data and 353 (75%) completed the study visit (median 44-month postpartum). At this time, outcomes were identical in both trial arms: 67% retained in care (P = 0.994) and 56% with viral loads <50 copies/mL (P = 0.751). Experiencing a gap in care after delivery was delayed in the MCH-ART arm with 17%, 36%, and 45% of women experienced a gap in care by 12-, 24-, and 36-months postpartum compared with 35%, 48%, and 57% in the standard of care arm, respectively. CONCLUSIONS: The benefits of integrated maternal HIV and child health care did not persist after transfer to general ART services. The transfer of women postpartum to routine adult care is a critical period requiring interventions to support continuity of HIV care.
BACKGROUND: Integrated maternal and child health (MCH) services improve women's postpartum antiretroviral therapy (ART) outcomes during breastfeeding; however, long-term outcomes after transfer to general ART services remain unknown. METHODS: The MCH-ART trial demonstrated that maternal retention and viral suppression at 12-months postpartum were improved significantly among women randomized to integrated MCH services continued in the antenatal clinic through cessation of breastfeeding (MCH-ART arm) compared with immediate transfer to general ART services postpartum (standard of care). We reviewed electronic health records for all women who participated in the MCH-ART trial to ascertain retention and gaps in care and invited all women for a study visit 36- to 60-months postpartum including viral load testing. RESULTS: Of 471 women in MCH-ART, 450 (96%) contributed electronic health record data and 353 (75%) completed the study visit (median 44-month postpartum). At this time, outcomes were identical in both trial arms: 67% retained in care (P = 0.994) and 56% with viral loads <50 copies/mL (P = 0.751). Experiencing a gap in care after delivery was delayed in the MCH-ART arm with 17%, 36%, and 45% of women experienced a gap in care by 12-, 24-, and 36-months postpartum compared with 35%, 48%, and 57% in the standard of care arm, respectively. CONCLUSIONS: The benefits of integrated maternal HIV and child health care did not persist after transfer to general ART services. The transfer of women postpartum to routine adult care is a critical period requiring interventions to support continuity of HIV care.
Authors: Hana Lee; Xiaotian K Wu; Becky L Genberg; Michael J Mugavero; Stephen R Cole; Bryan Lau; Joseph W Hogan Journal: AIDS Date: 2018-09-24 Impact factor: 4.177
Authors: Holly E Rawizza; Charlotte A Chang; Beth Chaplin; Isah A Ahmed; Seema T Meloni; Tinuade Oyebode; Bolanle Banigbe; Atiene S Sagay; Isaac F Adewole; Prosper Okonkwo; Phyllis J Kanki Journal: Curr HIV Res Date: 2015 Impact factor: 1.581
Authors: Amitabh B Suthar; David Hoos; Alba Beqiri; Karl Lorenz-Dehne; Craig McClure; Chris Duncombe Journal: Bull World Health Organ Date: 2012-11-28 Impact factor: 9.408
Authors: Andreas D Haas; Lyson Tenthani; Malango T Msukwa; Kali Tal; Andreas Jahn; Oliver J Gadabu; Adrian Spoerri; Frank Chimbwandira; Joep J van Oosterhout; Olivia Keiser Journal: Lancet HIV Date: 2016-03-09 Impact factor: 12.767
Authors: Landon Myer; Tamsin K Phillips; Allison Zerbe; Agnes Ronan; Nei-Yuan Hsiao; Claude A Mellins; Robert H Remien; Stanzi M Le Roux; Kirsty Brittain; Andrea Ciaranello; Greg Petro; James A McIntyre; Elaine J Abrams Journal: J Acquir Immune Defic Syndr Date: 2016-08-01 Impact factor: 3.731
Authors: Kirsty Brittain; Allison Zerbe; Tamsin K Phillips; Yolanda Gomba; Claude A Mellins; Landon Myer; Elaine J Abrams Journal: Glob Public Health Date: 2021-10-06
Authors: Jani van der Hoven; Elizabeth Allen; Annibale Cois; Renee de Waal; Gary Maartens; Landon Myer; Thokozile Malaba; Hlengiwe Madlala; Dorothy Nyemba; Florence Phelanyane; Andrew Boulle; Ushma Mehta; Emma Kalk Journal: BMC Pregnancy Childbirth Date: 2022-06-03 Impact factor: 3.105
Authors: Benjamin H Chi; Dorothy Mbori-Ngacha; Shaffiq Essajee; Lynne M Mofenson; Fatima Tsiouris; Mary Mahy; Chewe Luo Journal: J Int AIDS Soc Date: 2020-08 Impact factor: 5.396
Authors: Megan Landes; Monique van Lettow; Joep J van Oosterhout; Erik Schouten; Andrew Auld; Thokozani Kalua; Andreas Jahn; Beth A Tippett Barr Journal: PLoS One Date: 2021-03-12 Impact factor: 3.240